Abstract
Petr Kocis earned his Ph.D. in organic and medicinal chemistry at the Czechoslovak Academy of Sciences, Prague, Czechoslovakia. He did his postdoctoral research with Prof. Jack Baldwin, the University of Oxford, England and worked with the Oxford Enzyme Group. During the last two decades he has been involved in drug discovery research in cancer, immunodeficiencies, asthma and drug lead discovery at Hoechst-Marion-Roussell, Zeneca Pharmaceuticals and AstraZeneca, lately as Associate Director, Global Enabling Science & Technologies, and Principle Scientist II. Dr. Kocis is one of the pioneers of combinatorial chemistry field, he helped to build Selectides combinatorial chemistry and technology in Tucson, Arizona, in the early 90s. In the mid 90s he co-build the US Chemical Technologies group at Zeneca Pharmaceuticals and co-developed a novel combinatorial chemistry that was industrialized within the International Lead Drug Discovery as a part of modern medicinal chemistry. He is a recipient of the R & D Directors Award for Creativity and Innovation by Zeneca, and a recipient of the Henry Christian Award for Excellence in Research by Merck. He is on the editorial board of several journals including Drugs of the Future and on the Scientific Advisory Board of Cambridge Healthtech Institute. Dr. Kocis is the author or coauthor of numerous articles, book chapters and patents. His research interest is multidimensional challenges of drug discovery, modern medicinal and combinatorial chemistry, visualization and data mining.
Current Drug Discovery Technologies
Title: About Editor-in-Chief
Volume: 1 Issue: 1
Abstract: Petr Kocis earned his Ph.D. in organic and medicinal chemistry at the Czechoslovak Academy of Sciences, Prague, Czechoslovakia. He did his postdoctoral research with Prof. Jack Baldwin, the University of Oxford, England and worked with the Oxford Enzyme Group. During the last two decades he has been involved in drug discovery research in cancer, immunodeficiencies, asthma and drug lead discovery at Hoechst-Marion-Roussell, Zeneca Pharmaceuticals and AstraZeneca, lately as Associate Director, Global Enabling Science & Technologies, and Principle Scientist II. Dr. Kocis is one of the pioneers of combinatorial chemistry field, he helped to build Selectides combinatorial chemistry and technology in Tucson, Arizona, in the early 90s. In the mid 90s he co-build the US Chemical Technologies group at Zeneca Pharmaceuticals and co-developed a novel combinatorial chemistry that was industrialized within the International Lead Drug Discovery as a part of modern medicinal chemistry. He is a recipient of the R & D Directors Award for Creativity and Innovation by Zeneca, and a recipient of the Henry Christian Award for Excellence in Research by Merck. He is on the editorial board of several journals including Drugs of the Future and on the Scientific Advisory Board of Cambridge Healthtech Institute. Dr. Kocis is the author or coauthor of numerous articles, book chapters and patents. His research interest is multidimensional challenges of drug discovery, modern medicinal and combinatorial chemistry, visualization and data mining.
Export Options
About this article
Cite this article as:
About Editor-in-Chief, Current Drug Discovery Technologies 2004; 1 (1) . https://dx.doi.org/10.2174/1570163043484842
DOI https://dx.doi.org/10.2174/1570163043484842 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Intestinal Microbiota: A Regulator of Intestinal Inflammation and Cardiac Ischemia?
Current Drug Targets Endogenous Chemical Mediators in Anti-Inflammation and Pro-Resolution
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Transient Tachypnea of the Newborn: The Treatment Strategies
Current Pharmaceutical Design Probiotics: From Functional Foods to Pharmaceutical Products
Current Pharmaceutical Biotechnology Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives
Current Pharmaceutical Design Nutrapharmacology of Tocotrienols for Metabolic Syndrome
Current Pharmaceutical Design Modulation of Potassium Channels as a Therapeutic Approach
Current Pharmaceutical Design Chlorella vulgaris: A Multifunctional Dietary Supplement with Diverse Medicinal Properties
Current Pharmaceutical Design A Molecular Guidance System Based Upon Target Genes, Nuclear Receptors and Ligands Applied to Drug Discovery and Prediction of Toxicity
Mini-Reviews in Medicinal Chemistry Cigarette Smoke Exposure Inhibits Early Phase of Antibody Production through Inhibition of Immune Functions in Alveolar Macrophage
Current Respiratory Medicine Reviews Perspectives in Nanomedicine-Based Research Towards Cancer Therapies
Current Nanoscience Angiotensin-TGF-β1 Crosstalk in Human Idiopathic Pulmonary Fibrosis:Autocrine Mechanisms in Myofibroblasts and Macrophages
Current Pharmaceutical Design New Approved Medications for Idiopathic Pulmonary Fibrosis
Current Drug Therapy Licofelone-A Novel Analgesic and Anti-Inflammatory Agent
Current Topics in Medicinal Chemistry Acute Effects of Passive Smoking on Asthma in Childhood
Inflammation & Allergy - Drug Targets (Discontinued) Recent Aspects of Osmotic Pump Systems: Functionalization, Clinical use and Advanced Imaging Technology
Current Drug Metabolism Inhibiting Glutathione Metabolism in Lung Lining Fluid as a Strategy to Augment Antioxidant Defense
Current Enzyme Inhibition Biochemical Markers in the Prediction of Contrast-induced Acute Kidney Injury
Current Medicinal Chemistry The Panomics Approach in Neurodegenerative Disorders
Current Medicinal Chemistry Development of Montelukast Sodium Loaded Niosomal Carriers by Film Hydration Technique
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry